Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Regulatory News

Date Source Headline
24th Apr 2017 7:00 am RNS Diagnostics firm take rights to several Affimers
19th Apr 2017 7:00 am RNS Avacta to Present at the Shares Spotlight Evening
12th Apr 2017 7:15 am RNS Hardman Research: Another important box ticked
6th Apr 2017 2:23 pm RNS Holding(s) in Company
6th Apr 2017 2:23 pm RNS Holding(s) in Company
6th Apr 2017 10:22 am RNS Director/PDMR Shareholding
3rd Apr 2017 7:00 am RNS Interim Results for the Period Ended 31 Jan 2017
3rd Apr 2017 7:00 am RNS Results of Immunogenicity Study with Human Samples
31st Mar 2017 9:31 am RNS Avacta Presents at Investor Evening Hosted by TPI
31st Mar 2017 7:00 am RNS London Growth and Innovation Forum Presentation
22nd Mar 2017 9:00 am RNS Avacta to present at the UK Investor Show
21st Mar 2017 7:15 am RNS Hardman Research: Low response would be positive!
30th Jan 2017 7:00 am RNS Director/PDMR Shareholding
20th Jan 2017 11:35 am RNS Result of Annual General Meeting
20th Jan 2017 7:00 am RNS Trading Update
11th Jan 2017 7:00 am RNS Presenting at London Growth and Innovation Forum
5th Jan 2017 7:00 am RNS Director Dealing and Issue of Equity
20th Dec 2016 7:00 am RNS Director/PDMR Shareholding
16th Dec 2016 5:14 pm RNS Holding(s) in Company
1st Dec 2016 7:00 am RNS Notice of AGM, Accounts and Directorate Change
23rd Nov 2016 7:00 am RNS Technical Update: Affinity Separation
7th Nov 2016 7:00 am RNS Cancer Expert joins Scientific Advisory Board
2nd Nov 2016 7:00 am RNS CAR-T Cell Therapy Research Collaboration in US
1st Nov 2016 7:00 am RNS Results from first Affimer pre-clinical studies
21st Oct 2016 11:39 am RNS Director's Dealing
17th Oct 2016 1:00 pm RNS Hardman Research: Great strides to strategic goals
17th Oct 2016 7:00 am RNS Prelim Results for the Year Ended 31 July 2016
4th Oct 2016 3:28 pm RNS Issue of Equity
26th Sep 2016 11:21 am RNS Notice of Results
22nd Sep 2016 7:00 am RNS Positive results from first preclinical studies
12th Sep 2016 7:00 am RNS Change of Adviser
31st Aug 2016 2:17 pm RNS Change of Registered Office
16th Aug 2016 7:00 am RNS New Facilities in Cambridge and Wetherby
10th Aug 2016 7:00 am RNS Grant Funding
3rd Aug 2016 7:00 am RNS Key Affimer patents to be granted in Europe and US
1st Aug 2016 7:00 am RNS Trading Statement
19th Jul 2016 3:13 pm RNS Holding(s) in Company
19th Jul 2016 7:15 am RNS Hardman report: New Affimer opportunities
14th Jul 2016 7:00 am RNS Collaboration with Glythera
8th Jul 2016 7:00 am RNS Director/PDMR Shareholding
FTSE 100 Latest
Value9,100.77
Change0.00